1. Home
  2. NOVT vs BCPC Comparison

NOVT vs BCPC Comparison

Compare NOVT & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novanta Inc.

NOVT

Novanta Inc.

HOLD

Current Price

$127.64

Market Cap

4.7B

Sector

Miscellaneous

ML Signal

HOLD

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$161.85

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOVT
BCPC
Founded
1968
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Major Chemicals
Sector
Miscellaneous
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.6B
IPO Year
1999
1995

Fundamental Metrics

Financial Performance
Metric
NOVT
BCPC
Price
$127.64
$161.85
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$144.00
$176.00
AVG Volume (30 Days)
286.8K
175.0K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
0.55%
EPS Growth
N/A
20.87
EPS
1.47
1.25
Revenue
$521,290,000.00
$799,023,000.00
Revenue This Year
$8.61
$8.47
Revenue Next Year
$6.57
$4.89
P/E Ratio
$88.46
$34.24
Revenue Growth
35.49
13.56
52 Week Low
$98.27
$139.17
52 Week High
$149.95
$183.90

Technical Indicators

Market Signals
Indicator
NOVT
BCPC
Relative Strength Index (RSI) 52.27 32.95
Support Level $111.73 $160.21
Resistance Level $129.50 $166.47
Average True Range (ATR) 5.23 4.54
MACD -0.11 -1.50
Stochastic Oscillator 48.79 20.49

Price Performance

Historical Comparison
NOVT
BCPC

About NOVT Novanta Inc.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: